Filing Details
- Accession Number:
- 0001209191-21-049114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-02 18:44:54
- Reporting Period:
- 2021-07-29
- Accepted Time:
- 2021-08-02 18:44:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1662579 | C4 Therapeutics Inc. | CCCC | Biological Products, (No Disgnostic Substances) (2836) | 475617627 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1825445 | Adam Crystal | C/O C4 Therapeutics, Inc. 490 Arsenal Way #200 Watertown MA 02472 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-29 | 15,000 | $4.98 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-07-29 | 15,000 | $45.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-29 | 15,000 | $0.00 | 15,000 | $4.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
183,108 | 2030-07-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.
- This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020.